Life Science News
Latest updates from the biotech and pharma world
The ‘clever’ tool increasingly getting bigger biotech deals signed
UK agrees to boost drug prices to dodge US pharma tariffs
Regeneron inks gene editing deal with startup Tessera
Belite continues ascent as Stargardt drug hits mark in late-stage trial
With $130M, Protego pushes forward a new type of amyloidosis drug
Expanding access in oncology trials: The case for a paired tissue-plasma approach
Specialty pharmacy’s secret weapon: The unsung power of the enrollment form
From feedstocks to infrastructure, Indiana’s bioeconomy is on the move
Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3
Otsuka gains approval for first-of-its-kind treatment against rare kidney disease
CMS sets 2027 Medicare prices for Wegovy, Trelegy and 13 other drugs
Novartis wins approval to use SMA gene therapy in older patients
Gilead scoops up a preclinical cancer program
How do Big Pharma employees rate their CEOs?
Kelun, Merck tout ADC as potential first-line treatment in lung cancer
Bayer’s experimental blood-thinner notches trial win in stroke prevention
#Asundexian Phase#prevention Asundexian#study results#clinical setbacks#Phase
Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies
#Novo Nordisk#watched Alzheimer#misses goal#heart health#combat neurodegeneration
FDA probes effects of Takeda rare disease drug after patient death
#FDA probes#Takeda rare#neutralizing antibodies#probes effects#rare disease
Biogen strikes deal with Versant-backed biotech to expand immune portfolio
#Dayra Therapeutics#Versant-backed biotech#portfolio Newly#Newly launched#launched Dayra